Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
15.24
-0.85 (-5.28%)
At close: Oct 9, 2025, 4:00 PM EDT
15.13
-0.11 (-0.72%)
After-hours: Oct 9, 2025, 4:47 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Cell Engineering Revenue
187.24M173.97M
Log In
Log In
Log In
Upgrade
Biosecurity Product Revenue
--
Log In
Log In
Log In
Upgrade
Biosecurity Service Revenue
43.57M53.07M
Log In
Log In
Log In
Upgrade
Total Biosecurity Revenue
43.57M53.07M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-43.57M-53.07M
Log In
Log In
Log In
Upgrade
Revenue (Total)
187.24M173.97M
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Cell Engineering Operating Income
-51.84M-218.57M
Log In
Log In
Log In
Upgrade
Biosecurity Operating Income
-25.96M-30.62M
Log In
Log In
Log In
Upgrade
Corporate Operating Income
--310.57M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-235.52M-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-313.32M-559.76M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
New Programs
-52.00
Log In
Log In
Log In
Upgrade
Current Active Programs
-176.00
Log In
Log In
Log In
Upgrade
Cumulative Programs
-294.00
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.